FRED HUTCHINSON CANCER CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Employees: -

Market Cap: -

Website: https://www.fredhutch.org

Clinical Trials

Combination Chemotherapy, Peripheral Stem Cell Transplantation, and Radiation Therapy in Treating Patients With Ewing's Sarcoma, Peripheral Primitive Neuroectodermal Tumor, or Rhabdomyosarcoma

Phase 1

Completed

Conditions: Sarcoma

First Posted Date: 2004-04-27

Last Posted Date: 2010-09-20

Lead Sponsor: Fred Hutchinson Cancer Center

Target Recruit Count: 16

Registration Number: NCT00003081

Locations: 🇺🇸
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States

Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation

Phase 2

Completed

Conditions: Breast Cancer
Chronic Myeloproliferative Disorders
Gestational Trophoblastic Tumor
Kidney Cancer
Leukemia
Lymphoma
Multiple Myeloma and Plasma Cell Neoplasm
Myelodysplastic Syndromes
Neuroblastoma
Ovarian Cancer

First Posted Date: 2004-04-27

Last Posted Date: 2011-11-30

Lead Sponsor: Fred Hutchinson Cancer Center

Registration Number: NCT00003887

Locations: 🇺🇸
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States

Graft-Versus-Host Disease Prevention in Treating Patients Who Are Undergoing Bone Marrow Transplantation

Phase 3

Completed

Conditions: Graft Versus Host Disease
Leukemia
Lymphoma

First Posted Date: 2004-04-26

Last Posted Date: 2011-11-30

Lead Sponsor: Fred Hutchinson Cancer Center

Registration Number: NCT00002456

Locations: 🇺🇸
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States

Chemotherapy Plus Radiation Therapy and Biological Therapy in Treating Patients With Hematologic Cancer

Phase 2

Completed

Conditions: Leukemia
Lymphoma

First Posted Date: 2004-04-26

Last Posted Date: 2011-11-30

Lead Sponsor: Fred Hutchinson Cancer Center

Target Recruit Count: 50

Registration Number: NCT00002553

Locations: 🇺🇸
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States

Chemotherapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Solid Tumors

Phase 1

Completed

Conditions: Unspecified Adult Solid Tumor, Protocol Specific

First Posted Date: 2004-04-23

Last Posted Date: 2016-10-04

Lead Sponsor: Fred Hutchinson Cancer Center

Registration Number: NCT00003899

Locations: 🇺🇸
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States

Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma

Phase 2

Completed

Conditions: Multiple Myeloma and Plasma Cell Neoplasm

First Posted Date: 2004-04-23

Last Posted Date: 2011-06-23

Lead Sponsor: Fred Hutchinson Cancer Center

Registration Number: NCT00003146

Locations: 🇺🇸
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States

Paclitaxel With or Without Trastuzumab Following Peripheral Stem Cell Transplantation in Treating Patients With Refractory Stage IV Breast Cancer

Phase 2

Completed

Conditions: Breast Cancer

First Posted Date: 2004-04-23

Last Posted Date: 2010-04-02

Lead Sponsor: Fred Hutchinson Cancer Center

Target Recruit Count: 60

Registration Number: NCT00004013

Locations: 🇺🇸
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States

Melphalan and Stem Cell Transplant Before Total-Body Irradiation and Donor Stem Cell Transplant in Treating Patients With Stage I-III Multiple Myeloma

Phase 1

Completed

Conditions: Stage I Multiple Myeloma
Stage II Multiple Myeloma
Refractory Multiple Myeloma
Stage III Multiple Myeloma

Interventions: Drug: melphalan
Procedure: autologous hematopoietic stem cell transplantation
Procedure: autologous bone marrow transplantation
Procedure: peripheral blood stem cell transplantation
Radiation: total-body irradiation
Drug: cyclosporine
Drug: mycophenolate mofetil
Biological: therapeutic allogeneic lymphocytes

First Posted Date: 2004-04-15

Last Posted Date: 2020-02-06

Lead Sponsor: Fred Hutchinson Cancer Center

Target Recruit Count: 40

Registration Number: NCT00003954

Locations: 🇺🇸
University of Colorado, Denver, Colorado, United States
🇺🇸
City of Hope, Duarte, California, United States
🇺🇸
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States

and more 1 locations

Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Persistent or Platinum Refractory Stage III or IV Ovarian Cancer

Phase 1

Completed

Conditions: Ovarian Cancer

First Posted Date: 2004-04-14

Last Posted Date: 2010-09-15

Lead Sponsor: Fred Hutchinson Cancer Center

Registration Number: NCT00003080

Locations: 🇺🇸
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States

Monoclonal Antibody Therapy, Cyclophosphamide, and Total-Body Irradiation Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Recurrent Acute Lymphocytic Leukemia

Phase 2

Completed

Conditions: Leukemia

First Posted Date: 2004-04-14

Last Posted Date: 2010-04-02

Lead Sponsor: Fred Hutchinson Cancer Center

Target Recruit Count: 40

Registration Number: NCT00003870

Locations: 🇺🇸
University of Washington Medical Center, Seattle, Washington, United States
🇺🇸
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy